Is LT-673 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use LT-673? Is LT-673 safe for nursing mother and child? Does LT-673 extracts into breast milk? Does LT-673 has any long term or short term side effects on infants? Can LT-673 influence milk supply or can LT-673 decrease milk supply in lactating mothers?
Answer by DrLact: About LT-673 usage in lactation
No information is available on the clinical use of LT-673 during breastfeeding. Because LT-673 is 74% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during LT-673 therapy and for one month after the last dose.
Alternate Drugs
Ipilimumab(Unsafe)
Cyclophosphamide(Dangerous)
Nivolumab(Unsafe)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Cisplatin(Unsafe)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Busulfan(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Gemcitabine(Dangerous)
Dactinomycin(Dangerous)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Letrozole(Dangerous)
Bevacizumab(Low Risk)
Tamoxifen(Dangerous)
Exemestane(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Etoposide(Dangerous)
Pazopanib(Unsafe)
Doxorubicin(Dangerous)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)